APOLLO HOSPITALS ENTERPRISE LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 0.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Apollo Hospitals Enterprise Limited, the promoter of Indraprastha Medical Corporation Limited (IMCL), has filed a Regulation 31(4) disclosure with the stock exchanges. The filing confirms that the Apollo Hospitals Group held 22,917,500 equity shares in IMCL as on March 31, 2025, and that no encumbrance (such as pledge or lien) was created on these shares during the financial year. The shareholding is held across nine promoter-group entities, with Apollo Hospitals Enterprise Limited itself holding the largest chunk at 20,190,740 shares. This is a routine annual regulatory declaration required from promoters regarding pledging activity.
This is a neutral, routine filing. It reassures shareholders that the promoter has not pledged any of its stake in IMCL, indicating no immediate financial stress on the promoter. No impact on stock price is expected from this disclosure.